Ireland

--:--IST

Latest

How to Choose a CDMO in Ireland: A Practical Buyer's Guide Choosing a CRO for Clinical Trials in Ireland and Europe Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply How to Choose a CDMO in Ireland: A Practical Buyer's Guide Choosing a CRO for Clinical Trials in Ireland and Europe Ireland Needs 46,000 More Digital Specialists by 2030, EGFSN Report Warns Project Management Failures: Lessons for Healthcare FDA Approves Lilly's Weekly Insulin Onswik to Rival Awiqli WeBuild Programme: 50+ Women-Led Ventures and How to Apply

Subscribe

Registers› Irish medicines ›Originalis B.V.

Medicines register · Ireland

Originalis B.V. — licensed medicines

44 medicines held by Originalis B.V. on the Irish market, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 06 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Arimidex 1 mg film-coated tablets PPA2306/017/001

Anastrozole

Originalis B.V.

—

Aromasin 25 mg coated tablets PPA2306/015/001

Exemestane

Originalis B.V.

—

Cariban 10 mg/10 mg modified-release hard capsules PPA2306/040/001

DOXYLAMINE SUCCINATE, Pyridoxine hydrochloride

Originalis B.V.

—

Citidaron 1.5 mg tablets PPA2306/041/001

Cytisinicline

Originalis B.V.

—

CosmoFer 50 mg/ml solution for infusion and injection PPA2306/021/001

IRON (III)

Originalis B.V.

—

Coverdine 10mg/2.5mg/10mg film-coated tablets PPA2306/028/001

Perindopril arginine, Indapamide, Amlodipine

Originalis B.V.

—

Crestor 10 mg film-coated tablets PPA2306/038/002

Rosuvastatin

Originalis B.V.

—

Crestor 20 mg film-coated tablets PPA2306/034/001

Rosuvastatin calcium

Originalis B.V.

—

Crestor 5 mg film-coated tablets PPA2306/038/001

Rosuvastatin

Originalis B.V.

—

Decapeptyl 3-month, 11.25 mg Powder and solvent for suspension for injection PPA2306/022/001

Triptorelin

Originalis B.V.

—

Decapeptyl 6-month 22.5 mg Powder and solvent for prolonged-release suspension for injection PPA2306/022/002

Triptorelin

Originalis B.V.

—

Dostinex 500 microgram tablets PPA2306/035/001

Cabergoline

Originalis B.V.

—

ELIGARD 22.5 mg powder and solvent for solution for injection PPA2306/036/001

Leuprorelin acetate

Originalis B.V.

—

ELIGARD 45 mg powder and solvent for solution for injection PPA2306/037/001

Leuprorelin acetate

Originalis B.V.

—

Femara 2.5 mg film-coated tablets PPA2306/001/001

Letrozole

Originalis B.V.

—

Lamictal 100 mg tablets PPA2306/024/001

Lamotrigine

Originalis B.V.

—

Megace 40 mg/ml oral suspension PPA2306/016/001

Megestrol acetate

Originalis B.V.

—

Mezavant XL 1200 mg gastro-resistant, prolonged release tablets PPA2306/023/001

Mesalazine

Originalis B.V.

—

Midon 2.5 mg Tablets PPA2306/032/001

Midodrine hydrochloride

Originalis B.V.

—

Midon 5 mg tablets PPA2306/029/001

Midodrine hydrochloride

Originalis B.V.

—

Neotigason 25 mg capsules PPA2306/020/001

Acitretin

Originalis B.V.

—

Nexium 20 mg gastro-resistant tablets PPA2306/025/001

Esomeprazole

Originalis B.V.

—

Nexium 40 mg gastro-resistant tablets PPA2306/025/002

Esomeprazole

Originalis B.V.

—

Pentasa 1 g suppositories PPA2306/010/001

Mesalazine

Originalis B.V.

—

Pentasa Sachet 2g prolonged-release granules PPA2306/010/002

Mesalazine

Originalis B.V.

—

REMINYL 4 mg/ml oral solution PPA2306/012/001

Galantamine

Originalis B.V.

—

Reminyl XL 16 mg prolonged-release capsules, hard PPA2306/008/001

Galantamine

Originalis B.V.

—

Reminyl XL 24 mg prolonged-release capsules, hard PPA2306/009/001

Galantamine

Originalis B.V.

—

Requip-Modutab 4 mg prolonged-release tablets PPA2306/002/002

Ropinirole

Originalis B.V.

—

Requip-Modutab 8 mg prolonged-release tablets PPA2306/002/001

Ropinirole

Originalis B.V.

—

RISPERDAL 1 mg/ml oral solution PPA2306/007/001

Risperidone

Originalis B.V.

—

Seroquel XR 150 mg prolonged-release tablets PPA2306/011/002

Quetiapine

Originalis B.V.

—

Seroquel XR 400 mg prolonged-release tablets PPA2306/011/001

Quetiapine

Originalis B.V.

—

Solian 400 mg film-coated tablets PPA2306/019/001

Amisulpride

Originalis B.V.

—

Somatuline Autogel 120 mg solution for injection in a pre-filled syringe PPA2306/026/002

Lanreotide

Originalis B.V.

—

Somatuline Autogel 60 mg, solution for injection in a prefilled syringe PPA2306/026/001

Lanreotide

Originalis B.V.

—

TOPAMAX 100 mg Film-coated Tablets PPA2306/003/002

Topiramate

Originalis B.V.

—

Topamax 200 mg film-coated tablets PPA2306/003/001

Topiramate

Originalis B.V.

—

Trileptal 60 mg/ml Oral Suspension PPA2306/004/001

Oxcarbazepine

Originalis B.V.

—

Zarontin 250mg/5ml Syrup PPA2306/031/001

Ethosuximide

Originalis B.V.

—

Zofran Zydis 4 mg oral lyophilisate PPA2306/006/001

Ondansetron

Originalis B.V.

—

Zoladex LA 10.8 mg Implant PPA2306/027/001

Goserelin

Originalis B.V.

—

Zovirax 800 mg Dispersible Tablets PPA2306/030/001

Aciclovir

Originalis B.V.

—

Zyban 150 mg prolonged release tablets PPA2306/005/001

Bupropion hydrochloride

Originalis B.V.

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 6 October 2026. https://priyalifescience.com/medicines/company/originalis-b-v

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.